BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,150.00
-20.00 (-0.39%)
Last updated: Apr 29, 2026, 2:16 PM KST

BioNote Revenue

In the year 2025, BioNote had annual revenue of 118.32B KRW with 15.12% growth. BioNote had revenue of 27.97B in the quarter ending December 31, 2025, with 13.05% growth.

Revenue
118.32B
Revenue Growth
+15.12%
P/S Ratio
4.41
Revenue / Employee
397.06M
Employees
298
Market Cap
522.33B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025118.32B15.54B15.12%
Dec 31, 2024102.78B12.70B14.10%
Dec 31, 202390.08B-389.58B-81.22%
Dec 31, 2022479.66B-142.70B-22.93%
Dec 31, 2021622.36B-9.15B-1.45%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
T&L Co., Ltd. 164.16B
Value Added Technology 426.42B
Vieworks 239.33B
Dongbang Medical 113.54B
Shinhung 102.61B
CLASSYS 336.82B
EOFLOW 3.67B
PCL, Inc. 4.98B
Revenue Rankings